SCHOTT Pharma AG & Co. KGaA (BIT:1SXP)

Market Cap	2.57B -34.8%
Revenue (ttm)	991.22M +1.8%
Net Income	142.82M -3.5%
EPS	0.95 -3.0%
Shares Out	n/a
PE Ratio	17.99
Forward PE	16.94
Dividend	0.18 (1.09%)
Ex-Dividend Date	Feb 4, 2026

Volume	120
Open	16.50
Previous Close	16.46
Day's Range	16.50 - 16.90
52-Week Range	13.18 - 30.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 13, 2026

About BIT:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold application...

• Industry: Glass Containers
• Founded: 1884
• Employees: 4,839
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1SXP

Financial Performance

In fiscal year 2025, BIT:1SXP's revenue was 986.21 million, an increase of 3.04% compared to the previous year's 957.09 million. Earnings were 146.45 million, a decrease of -2.16%.